April 26, 2017 7:36 PM ET

Pharmaceuticals

Company Overview of Naia Rare Diseases Inc.

Company Overview

Naia Rare Diseases Inc. developing drugs for rare gastrointestinal diseases. The company is headquartered in the United States. Naia Rare Diseases Inc operates as a subsidiary of Naia Limited.

,  

United States

Key Executives for Naia Rare Diseases Inc.

President, Chief Executive Officer, and Chairman
Age: 66
Compensation as of Fiscal Year 2016.

Naia Rare Diseases Inc. Key Developments

Naia Rare Diseases Announces Investigational New Drug Application Submission to Initiate Clinical Trials of NB 1001 for Short Bowel Syndrome

Naia Rare Diseases announced that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to initiate a Phase 1b clinical trial for its long-acting GLP-1 agonist, NB 1001, in adult patients with SBS. NB1001 will be administered as a replacement therapy (replacing endogenous GLP-1 lost by bowel resection), in contrast to GLP-1 agonists used to treat Type 2 diabetes, which are administered at pharmacologic levels in order to lower blood sugar. Lower doses of NB1001 combined with a longer half-life will provide a differentiated, safe, effective and convenient therapeutic approach for these patients.

Naia Rare Diseases, Inc. Presents at 28th Annual ROTH Conference, Mar-15-2016 04:00 PM

Naia Rare Diseases, Inc. Presents at 28th Annual ROTH Conference, Mar-15-2016 04:00 PM. Venue: The Ritz Carlton, 1 Ritz Carlton Drive, Laguna Niguel, Dana Point, California, United States.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
April 3, 2017
--
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Naia Rare Diseases Inc., please visit naiapharma.com/rare-diseases. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.